THIS MANUAL WAS
DEVELOPED BY:
Laura Weingartner, PhD, MS1
Emily Noonan, PhD, MA1
Amy Holthouser, MD1
Jennifer Potter, MD2,3
Stacie Steinbock, MEd1
Suzanne Kingery, MD1
Susan Sawning, MSSW1

HOW TO CITE THIS MANUAL

Weingartner LA, Noonan EJ, Holthouser A, Potter J, Steinbock S, Kingery S, Sawning S. The
eQuality Toolkit: Practical Skills for LGBTQ and DSD-Affected Patient Care. Lexington, KY:
University Press of Kentucky; 2019. doi: 10.18297/faculty/391

ACKNOWLEDGEMENTS

The development of this manual and related research was funded by The National Institute for
Health Care Management (NIHCM) Foundation. We thank the institute for supporting novel
and critical research into LGBTQ and DSD health care.
We also thank the numerous LGBTQ and DSD-affected community members in Louisville for
their invaluable feedback on content. The eQuality project would not have been possible without
the generous time, energy, and expertise that LGBTQ and DSD-affected community members
and leaders have provided to the University of Louisville School of Medicine (ULSOM).
We would like to thank the eQuality Steering Committee, including Dr. M.
Ann Shaw, Vice Dean for Undergraduate Medicine Education of ULSOM,
for their time and leadership on the eQuality project. The staff of the
LGBT Center have also worked tirelessly to sustain strong community involvement in this project. The ULSOM Standardized Patient
Program and the ULSOM Medical Education Research Unit have
provided extensive support to eQuality.
Finally, we also acknowledge Dr. Toni Ganzel, Dean of ULSOM,
whose leadership and continued support have been vital to the
establishment and success of eQuality.

University of Louisville
Harvard Medical School
3.
The Fenway Institute
1.

2.

THE eQUALITY TOOLKIT: PRACTICAL SKILLS FOR LGBTQ
AND DSD-AFFECTED PATIENT CARE
CONTENTS
PREFACE: HOW TO USE THIS MANUAL

1

PART I: INCLUSIVE COMMUNICATION SKILLS
AN ACTIVE PARTNERSHIP WITH THE PATIENT
AVOIDING ASSUMPTIONS
INCLUSION ON FORMS AND IN CONVERSATION
CONVERSATIONS WITH LGBTQ/DSD-AFFECTED YOUTH
REFERRAL NETWORKS AND BEST PRACTICES
ADDRESSING MICROAGGRESSIONS

3
4
5
9
10
11

PART II: GENDER-AFFIRMING CARE
AVOIDING ASSUMPTIONS ABOUT TRANSITIONING
PATIENTS BORN WITH DSD
HORMONE THERAPY
GENDER-AFFIRMING SURGERY
CONSIDERATIONS FOR TRANS AND DSD-AFFECTED YOUTH

12
13
14
16
17

PART III: PREVENTIVE CARE
FRAMEWORK FOR TRAUMA-INFORMED CARE
SCREENINGS
VACCINES
REPRODUCTION AND FAMILY PLANNING

19
19
23
24

PART IV: SOCIAL DETERMINANTS OF HEALTH
SOCIAL DETERMINANTS OF HEALTH
LEGAL AND INSURANCE CONSIDERATIONS

28
30

PART V: SENSITIVE PHYSICAL EXAMS
KNOW YOUR PATIENT
INCLUSIVE LANGUAGE FOR EXAMS AND ENCOUNTERS
STRATEGIES AND OPTIONS TO OPTIMIZE COMFORT

31
31
32

CONCLUSION

35

APPENDICES
APPENDIX A: NATIONAL RESOURCES
APPENDIX B: GLOSSARY
APPENDIX C: TOOLKIT REFERENCES

36
38
42

THE EQUALITY TOOLKIT: PRACTICAL SKILLS FOR LGBTQ AND
DSD-AFFECTED PATIENT CARE

PREFACE
WHAT IS THE PURPOSE OF THE eQUALITY TOOLKIT?

This manual will help providers build a foundation of inclusive clinical skills to competently care
for lesbian, gay, bisexual, transgender, and queer-identified (LGBTQ) patients and individuals
born with differences of sex development (DSD, sometimes called intersex). Although this toolkit
was designed for medical students, any healthcare provider who wants to learn inclusive clinical
skills can benefit from this manual. Other published resources address LGBTQ/DSD health and
clinical skills comprehensively (see Appendix A). The purpose of this manual is to provide a brief
primer that is accessible to all medical students with actionable steps to improve clinical care. It
was specifically written for use at the University of Louisville School of Medicine; therefore, some
resources or laws may be region/city specific. However, most of the content is applicable to any
provider caring for LGBTQ/DSD patients.

The number of people who identify as LGBTQ is growing,
including 7.3% of millennials.1 DSD is estimated to affect
1.7% of births.2,3 These individuals are our patients, and it is
our responsibility to learn how to provide quality care for
them.

WHY IS THIS MANUAL NEEDED?

Simply, this manual addresses gaps in healthcare provider training in caring for LGBTQ/DSD
communities. These populations experience repeated instances of stigma and discrimination
related to their identities, with consequent health and healthcare disparities that knowledgeable
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healthcare providers can help to address.4-9 In 2015, the University of Louisville School of Medicine (ULSOM) established eQuality (louisville.edu/medicine/equality/), an inclusive LGBTQ/
DSD health training program that was integrated across the mainstream medical student curriculum.10 After launching eQuality, we realized our students needed more clinical skills training to
translate classroom learning into patient care. Although the focus of this manual is LGBTQ/DSD
health, much of this content is applicable to all patients and can be incorporated broadly.

LGBTQ/DSD health and healthcare disparities are staggering, including:
—LGB individuals are as much as 2.5x likelier to smoke11
—40% of transgender individuals attempt suicide12
—Cardiovascular disease risk is 2x higher for LGB adults13
—LGBTQ individuals are likelier to be uninsured than others4

HOW TO USE THIS MANUAL

This manual has been used to train medical students in a classroom setting. However, it can function independently as a clinical skills supplement for practicing providers. Its five sections address
the main sources of provider-driven health disparities and biases for the LGBTQ/DSD communities. This manual could be used as a supplement to a longitudinal clinical skills training course
during medical school or in stand-alone LGBTQ/DSD health training. Although it is a primer, it
may also be appropriate for graduate medical education (GME) training and as a faculty development tool. As you encounter terminology that is not familiar to you, please see the glossary in
Appendix B for definitions.

LIMITATIONS

The purpose of this manual is to provide a brief introduction for students, and making this
practical necessitates the distillation of many complex subjects. For instance, we use the umbrella
terms LGBTQ/DSD in this manual, which do not reflect the vast diversity of sexual and gender minority communities (see figure below and Appendix B for examples of sexual and gender
identities). It is important to remember that terminology is fluid and ever changing. Therefore,
the best strategy for providers is to have an open dialogue with patients to learn the words they
use. Appendix A contains a list of resources for more comprehensive consideration of the topics in
this manual.
Supporting research informs our recommendations, but many federal guidelines lag behind the
expertise of providers who work extensively in LGBTQ/DSD health. We provide peer-reviewed
citations in this manual to help inform your decision-making. Reasons to depart from guidelines
include 1) the lack of an apropos guideline for your patient, and 2) the need for shared decision-making with the patient (e.g., to still prescribe estrogen in the context of a history of atherosclerotic cardiovascular disease). If departing from guidelines, a physician should be aware of
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how other considerations, such as insurance coverage, may influence these decisions (see Part IV).
Finally, LGBTQ/DSD health is an evolving field, and the authors will make efforts to periodically
update this manual with current information. The information in the following sections
represents best practice as of the time of this writing.

PART I: INCLUSIVE COMMUNICATION SKILLS
CREATING AN ACTIVE PARTNERSHIP WITH THE PATIENT

Many members of the LGBTQ/DSD-affected community have had previous negative experiences
within the healthcare system.5,12,14,15 One of the provider’s responsibilities is to ensure that the patient’s previous experiences—both in life and in health care—are considered when discussing different treatment options. LGBTQ individuals comprise approximately 5% of the U.S. population
and this proportion is growing,1 and these best practices can therefore have a substantial impact.
An active partnership can be developed by asking a patient open-ended questions such as “Tell
me about your pain” versus “Does this hurt?”16,17 The former allows the patient to elaborate with
more insightful responses. Close-ended questions, while more direct, require the provider to infer
information about the patient. When provider assumptions about a patient’s sexual or gender
identity are incorrect, the patient is left having to choose between correcting the provider or leaving the mistake unaddressed, resulting in suboptimal care that contributes to health disparities.
The sections below will help providers develop active partnerships will all patients.
Providers can encourage openness with all patients by intentionally explaining provider-patient
confidentiality, which is particularly important for patients who have previously endured bias
and discrimination. Establishing trust by ensuring confidentiality can be especially important for
gathering an accurate sexual history, regardless of patient identity. Patients should be explicitly

communication skills
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told what information will be recorded in their medical record, if and how this information will
be shared (e.g., with insurance companies), and when confidentiality cannot be protected (e.g.,
mandatory reporting requirements for some diseases, abuse, and the potential for harm to self and
others). Providers should seek permission from the patient to include identifying information in
the medical record.

Considerations should be made for LGBTQ and DSD-affected
patients, including youth, who may be concerned about
being unintentionally “outed” to others or parents.

AVOIDING ASSUMPTIONS

Knowing about a patient is necessary to provide accurate, quality care. A patient’s identities,
attractions, and behaviors all impact health risks and social-behavioral determinants of health,
such as employment or housing access. The LGBTQ/DSD community also intersects with all
races, ages, and cultures. When meeting a new patient, it is not possible to know the person’s
sexual orientation or gender identity by appearance. To avoid assumptions about sexual and
gender identity, providers must ask, and research shows that patients want physicians to do so!18,19
(See page 7 for an example of dialogue.) Inclusion is the best way to start a successful relationship
with LGBTQ/DSD patients, and these steps are no cost to non-LGBTQ/DSD patients because
common questions/discussions can be framed in an inclusive manner that is appropriate for all
patients.
Furthermore, labels often mean different things to different people, and occasionally identities
may not match behavior. Studies have found that some straight-identified men engage in samesex sexual behavior.20 Similarly, higher pregnancies have been documented among lesbian-identified youth, possibly because providers do not provide contraceptive counseling to individuals
assumed to engage only in same-sex behavior.21 Behavior that is discordant with identity would
not be captured by an intake form asking only for sexual orientation. This highlights the importance of understanding not just the identities but also the behaviors of patients, a best practice
that holds true of all patients, not just patients who identify as LGBTQ/DSD. Such biases in the
healthcare system can impact patient care.

4
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INCLUSION ON FORMS AND IN CONVERSATION

Inclusive intake forms help to make the collection of this information commonplace and give
providers more context to the patient’s background. Providers may also rotate or work at locations that do not have inclusive registration forms. We suggest talking to administration to
address this—prompt attention can make a meaningful difference—and there are many templates
available (see resources in Appendix A). Examples of typical registration form questions and more
inclusive options can be seen on the following page.

Collecting and using preferred names avoids unintentionally
“outing” transgender patients (to other patients in the waiting
rooms, staff not on the care team, etc.).22

Asking detailed information on an intake form does not discriminate against the majority because
everyone has a sexual orientation and gender identity to disclose. During the patient/physician
visit, providers will want to ask the patient how they identify. Asking again in person is important
because some patients will not disclose sexual orientation and/or gender identity on a form that
could be linked to their health record because of discrimination concerns.

communication skills
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Some patients will not want to disclose sexual orientation and/or
gender identity on a form that could be linked to their health record.
Discrimination is real for many LGBTQ community members (the state of
Kentucky, for example, does not protect LGBTQ people from employment
or housing discrimination at the time this manual was written). Ideally,
we are moving toward a society that treats all people equally regardless
of identity, but until this point, some patients may be hesitant to put
sensitive information on official forms.
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Because discussing this important information is not yet commonplace, providers may want to
explain to patients why they ask for it. It is important to ask these questions to every patient—regardless of whether or not a provider thinks the patient is straight, cisgender, gender conforming,
or has a history of opposite sex activity. Asking all patients addresses the provider’s own biases,
assumptions, and stereotypes.7 Practicing these questions will make the provider feel more at
ease asking them over time and will normalize the conversation with all patients. Asking patients
about same-sex sexual behavior or attraction typically results in larger population estimates of
sexual minority status compared to asking people whether they identify as part of the LGBTQ
community.23

“I don’t want to offend my patients.” Many providers hesitate
to ask about identities out of concern for offending non-LGBTQ/
DSD patients. These concerns are largely unwarranted because 1)
all patients have answers to these identity questions, and 2) most
patients understand if providers approach this conversation as
a routine part of the patient history. If a patient were to respond
negatively, providers should reiterate that every patient is asked
these questions. Here is an example dialogue:
Provider: “I ask these questions of all of my patients so that I can
give you the best care possible. What pronouns do you use?”
Patient: “Don’t I look like a woman to you?”
Provider: “Of course. These are questions that I ask all of my
patients to make sure I understand who they are. I’ll use she,” and
then continue to the next question.

communication skills

7

Below are suggestions for taking an inclusive medical history in person to help avoid assumptions
(see Part V for inclusive language choices for specific body parts and bodily processes). These
questions also signal to patients that they can talk to a provider in the future about any concerns.
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CONVERSATIONS WITH LGBTQ/DSD-AFFECTED YOUTH

Healthcare providers can assist youth who were born with a DSD, identify as LGBTQ, or who are
questioning their sexual or gender identities. For DSD-affected individuals, sexual orientation and
gender identity cannot be assumed by the provider; this highlights the importance of having these
discussions with all patients. Provider support is particularly crucial if the patients have insufficient support at home and/or school. Adverse childhood experiences (ACEs), including abuse,
household dysfunction, abandonment, and rejection are common (although not universal) for
LGBTQ youth, and these experiences often lead to adverse mental and physical health effects.25
Providers can help determine if young patients are at risk. Providing a supportive, welcoming
environment is the first step. Providers may ask to discuss some more sensitive topics without the
parent present to reduce the patient’s stress and allow for a more comfortable, honest discussion.7

Before disclosure, providers should understand and explain to the youth patient what obligation
they have to notify parents and also what confidentiality a provider can give to the patient. Laws
governing minor consent and parental access to health information of minors vary by state. In
Kentucky, for instance, patients under 18 years old can seek treatment for STIs, contraception,
pregnancy (not including sterilization or abortion), and substance abuse without parental/guardian notification.31 Age of consent laws also vary by state, but providers are mandated to report
minors who disclose sexual activity before this age (as well as any significant safety concerns) to
child protective services. Gender identity and sexual orientation are not specifically covered under
the law, but are usually regarded by healthcare providers as protected information that would not
be discussed with a parent without the consent of the patient. Optimal care for the minor patient
usually includes family support and disclosure. However, due to family rejection and domestic
violence concerns for LGBTQ youth, the safety of the patient following disclosure has to be balanced with the wish of the provider to inform parents.

communication skills
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REFERRAL NETWORKS AND BEST PRACTICES

Many LGBTQ patients and patients with a DSD have experienced healthcare providers refusing
to care for them, refusing requested care, and/or committing micro or overt aggressions that reject
their humanity.12,32 These incidents occur at a time that patients are incredibly vulnerable, such as
going to the doctor’s office, emergency room, hospital, or operating room.

Medical students desire to provide effective, evidenced-based, compassionate, affirmative care to
LGBTQ patients,33 but medical education has not traditionally provided an effective framework
for physicians to provide LGBTQ health care.34 This manual is clear in its intent to positively
impact patient care by providing those willing and invested in improving health outcomes for
LGBTQ/DSD patients the information necessary for them to care for their patients. If providers
work with others who choose to refer LGBTQ/DSD patients, they should ensure it is done with
the patient’s well-being in mind. It is not appropriate for the provider to describe personal beliefs
or make judgments that contribute to bias and discrimination, which can thus discourage the
patient from seeking future preventive and diagnostic health care and do harm to the patient.
Providers should use neutral, nonjudgmental language that assures patients that their needs will
be taken into account.
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ADDRESSING MICROAGGRESSIONS

Even if a provider creates an inclusive space, issues with other members of the team—from the
front desk to nursing staff to attending physicians—can create a hostile or even dangerous environment for patients. Many patients who are LGBTQ/DSD report experiencing microaggressions
(comments that are subtly or unconsciously prejudiced and hurtful) in healthcare offices, as well
as overt harassment and discrimination in some instances (such as verbal abuse, rough physical
exams, or refusal to treat).12 Healthcare providers have a responsibility to ensure that patients
experience a welcoming environment. As a bystander/upstander and ally, every provider should
be ready to intervene on behalf of an LGBTQ/DSD patient (or co-worker, etc.). Providers should
practice supporting the person targeted by the microaggression in order to prioritize that individual’s well-being, and then address the source (taking advantage of opportunities to educate
others). Here are some examples of common microaggressions and possible responses:

Medical students may have to address microaggressions—often made unintentionally—from
higher-ups, such as residents and attending physicians. If a student feels comfortable “teaching
up” in a situation, they may explain to the team how the microaggression is offensive and offer
more inclusive options. If the student is not comfortable in this role in the setting of the microaggression, it is important to give feedback to a trusted supervisor or administrator in the clinical
or educational environment (for example, a clerkship director or coordinator) so that additional
education can occur.

communication skills
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PART II: GENDER-AFFIRMING CARE
AVOIDING ASSUMPTIONS ABOUT TRANSITIONING

Gender-affirming care is appropriate and supportive care for the patient’s complete gender identity. Establishing whether a patient is cisgender, transgender, or was born with a DSD is best done
through the two-step gender identity questions (see Part I) to determine whether gender identity
(step one) matches sex assigned at birth (step two), and to determine what pronouns the patient
uses. This section discusses additional considerations for effectively providing care for patients
whose gender identity does not match their sex assigned at birth. This section will refer to patients
seeking this care using the umbrella terms transgender and DSD for brevity, but there are many
gender identities that apply here such as nonbinary, genderqueer, gender fluid, and more (See
Appendix B).
Below we discuss medical and surgical interventions that can help affirm transgender patients’
identities. The starting place for gender-affirming care is to realize, however, that not every patient’s transition will be the same. Consider the parallel between transitioning and starting a family—not every person wants children, and sometimes life circumstances take priority. Similarly,
some transgender patients never want medical or surgical interventions as part of their transition,
and sometimes insurance issues complicate these choices (see Part IV). There is no single path
that any transgender patient should follow, so it is best to ask open-ended questions like “can you
tell me about your transition goals?” when taking a history and discussing gender identity and/
or goals of hormone use or surgery. This allows the patient to take charge of their personal aims
and allows the provider to address any questions the patient has. With the wide array of online
resources for transgender health, many patients are well informed about their options and goals.
The provider’s responsibility is to help place their transitioning goals into the context of their
medical care.

12
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Some care guidelines recommend that a person live openly within
the new or desired gender identity for a set period of time and/or
provide a referral letter from a mental health professional before
providers prescribe medications or surgery for gender-affirming
care. However, this recommendation is evolving, and more recent
practices focus on enhancing self-esteem and mental well-being
by partnering with the patient to prescribe desired treatments
earlier to help match the patient’s internal experience with their
desired external appearance more completely and expeditiously. The
informed consent process allows providers to develop a plan with
the patient who demonstrates an understanding of risks, benefits,
and implications of treatment; providers document the conversation
in the medical record to indicate informed consent was obtained
(patient signature not required).

The World Professional Association for Transgender Health (WPATH), the international body
of experts on transgender care, has determined that gender-affirming procedures are medically
necessary for those transgender patients who desire them as part of their transition.8 Ultimately
the risks of feminizing and masculinizing therapy need more data to be conclusive, but there is
an overwhelming benefit to addressing gender dysphoria for transgender patients. Hormonal interventions used in transition are associated with decreased depression and anxiety.36 Recent data
show that 40% of transgender people attempt suicide,12 so many LGBTQ providers see suicidal
ideation risk as a more pressing health issue than possible side effects of hormone therapy. The key
point is for providers to become informed and prescribe gender-affirming care based on the
transition desires of their patients!

PATIENTS BORN WITH DSD

DSD-affected individuals may not have the anatomy and/or hormonal composition typical
of a natal male or natal female. DSDs are diverse, and knowing an individual’s anatomy and
hormones is necessary to provide appropriate preventive screening and counseling. For some
DSD-affected patients, gender identity will have been determined during infancy or childhood
by their providers and/or parents, although advocates are working hard to change this.5 Many
DSD-affected individuals have had prior negative healthcare experiences because their family and
providers did not explain their condition or failed to discuss all available treatment options,37 and/
or because of voyeurism (unnecessary exams or additional members of the healthcare team present

gender-affirming care
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“to learn”).38-39 Healthcare providers should fully disclose the DSD diagnosis and all potential
treatment options from the outset, and ask patients about their prior healthcare experiences. This
approach supports the development of a shared decision-making model that is in the best interest
of the patient. Finally, it is important to remember that having a DSD does not determine a
patient’s sexual orientation, attraction, or sexual behavior.

HORMONE THERAPY

The purpose of hormone therapy is to alter secondary sex characteristics to more closely match a
person’s gender identity rather than their sex assigned at birth. Not all patients desire hormones
as part of their transition. For those who do, people who identify on the male-to-female spectrum
typically take estrogen and antiandrogens (which reduce the dose of estrogen needed),40 while
people on the female-to-male spectrum typically take testosterone.41 Some physical changes are
irreversible, and thus patients should be informed about this as part of the informed consent
process before beginning hormone therapy. Special considerations for transitioning prior to the
onset of puberty are addressed separately below. Although the timeline of the physical effects of
hormone therapy are variable, most changes occur in two years. The WPATH Standards of Care8
(SOC) detail expected onset times, maximum effect, and reversibility (and also note that a new
SOC revision is expected soon with updates since the 2012 version 7). The Center of Excellence
for Transgender Health also has detailed feminizing and masculinizing dosage guidelines.6

Who can administer hormones? When approaching a general practitioner for a hormone
prescription, many transgender patients are “handed off” to endocrinologists because the provider feels they lack the knowledge to administer and monitor hormones. Referrals place a burden
on the patient, and many experts assert that hormone therapy does not need to be performed
specifically by an endocrinologist.6 Primary care physicians, obstetrician-gynecologists, nurse prac-
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titioners, and endocrinologists have the capacity to administer gender-affirming hormones, and
many have experience with the hormones in other contexts (e.g., contraception or menopause).42
What are the risks of hormone therapy? A major barrier to care is providers’ overestimation of
cross-sex hormone therapy risks, which is usually related to a lack of clinical experience or training with this practice. Introducing hormones in any person comes with risks, but risks are not
known to be higher for transgender patients. For instance, estrogen carries a risk of blood clots
whether it is used in a cisgender female patient (FSAAB) or transgender female patient (MSAAB),
with oral hormones being riskier than injections for both.43 The risks of hormone therapy are
often cited as a reason for a provider not to initiate hormone therapy or to refer the patient to
an endocrinologist. Often this is unfounded—few data definitely show increased risk. Results
from comprehensive studies, such as the recently established Study of Transition, Outcomes and
Gender (STRONG),44 are needed to determine the actual long-term risks of hormone therapy to
transgender patients.6,8

It is the provider’s responsibility to inform the patient of possible risks to ensure a patient’s informed consent before starting hormone therapy. However, requiring patients to continually see a
specialist for gender-affirming care can create healthcare disparities by placing a greater burden on
the patient through fractured and delayed care, which can contribute to poor mental health outcomes and even suicide. In some cases, it may be desirable for the provider to consult an endocrinologist or subspecialist to first create an overall plan of care, but a competent primary care doctor
can then provide continuing care and monitor the patient’s hormone levels and progress.

gender-affirming care
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GENDER-AFFIRMING SURGERY

Some transgender patients may desire irreversible surgical procedures to obtain physical features
that more closely align with their gender identity. Note that these surgeries include a wide range
of possible procedures, including several that are not specific to transgender patients (e.g., hysterectomy).40,41 Possible surgical procedures also include more than just genital removal or reconstructive surgeries. A good understanding of each patient’s pre- and postsurgical anatomy is crucial to guide routine preventive care, screening decisions, and diagnostic care decisions if problems
occur in the future. It is crucial that each patient’s medical record reflect that individual’s pre- and
postsurgical anatomy so that it can be considered by all care providers, such as when an additional
provider is covering for the primary provider, or is consulted in some aspect of the patient’s care.
The effect of gender-affirming surgery on screening and preventive care will be addressed in Part
III. Transgender patients may consider any (or none) of the following surgical interventions:
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CONSIDERATION FOR TRANSGENDER AND DSD-AFFECTED YOUTH

Transgender youth who have not yet experienced puberty may benefit from starting hormone
therapy before innate hormones change secondary sex characteristics in a way that does not
match the youth’s gender identity. Many transgender adolescents will desire puberty blockers and
benefit from intensive counseling and support as they consider their desired goals of transition.
Puberty blockers can be advantageous since they prevent physical changes associated with innate
hormones. They can allow questioning youth time to explore their gender development, and the
effects are reversible should a patient choose to discontinue their gender transition.45
The process of puberty varies for individual adolescents, so timing of hormone administration
can be difficult to determine. It may be more desirable for a pediatric endocrinologist to manage
hormones for youth patients since puberty is being initiated with hormones, and hormone levels
in children/adolescents differ from those in adults—so standard reference ranges may not apply.
However, there are many circumstances in which a highly qualified and experienced primary
care provider can manage and/or partner with a pediatric endocrinologist for the care of young
patients. Some organizations suggest that hormone therapy for adolescents can be managed by a
qualified primary care provider similar to the manner in which it is managed for adults.6 However, this is not currently the norm.
When a DSD is identified for an infant or child, the individual with the DSD is unable to make
an informed decision or consent to treatment. In the past, parents and/or providers have been
given the responsibility for making this important decision, but current providers for DSD-affected patients advocate that any nonurgent procedures—particularly those that are irreversible, such
as surgery for ambiguous genitalia—be delayed until the child is old enough to make an informed
decision about gender identity.46 Providers treating a child with DSD should consider the current
well-being of the child and that of the future adult, the child’s future right to be informed and in
control of their own healthcare decisions, and the well-being of the child-parent relationship.46

gender-affirming care
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Learning a patient’s gender identity is a two-step process: establishing
sex assigned at birth and establishing how the patient identifies. Sex
assigned at birth is vital for providing sex-specific care. Affirming a
patient’s identity (e.g., by using the pronouns the patient uses—such as
he, she, or they) shows respect and builds a trusting relationship that will
keep the patient engaged in the healthcare system. The goal is to reduce
health and healthcare disparities, and facilitating a positive patientcentered relationship through understanding and affirming patients’
identities supports this goal.
If a provider misgenders a patient, respectfully acknowledge the
mistake to indicate that it was noticed and unintentional, correct the
mistake, and continue with the patient encounter while ensuring that
affirming language is used. The provider can apologize if desired,
although lingering on the mistake can be counterproductive because
the conversation becomes centralized on the person’s gender rather
than on the person’s care. This process can also be applied to mistaken
assumptions about sexual orientation, such as a partner’s gender.
However, asking all patients about gender identity and sexual orientation
helps providers avoid making mistakes rather than needing to correct
them.

18
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PART III: PREVENTIVE CARE
FRAMEWORK FOR TRAUMA-INFORMED CARE

Many individuals experience repeated harassment, discrimination, and/or abuse related to their
LGBTQ/DSD status.12,47,48 In addition, many DSD-affected individuals have had unnecessary and/or painful and invasive surgeries, and their DSD status was withheld until well into
adulthood. These traumatic experiences can lead to mistrust of the medical community. Caring
for LGBTQ/DSD patients requires providers to realize the ubiquity of trauma, recognize the
symptoms and signs of trauma, acknowledge its effects, and shift from a pathologizing stance of
“What’s wrong with you?” to the much more helpful “What happened to you, and how can I
help you cope best?” A trauma-informed approach can improve interactions with all patients.49

SCREENINGS

No genetic differences predispose members of the LGBTQ community to diseases. Differences
in disease burden can thus be linked to adverse healthcare experiences, consequent avoidance
of preventive care, provider ignorance about necessary screenings for different populations, lack
of insurance, and increased health risk behaviors (which often represent attempts to cope with
sex- or gender-related minority stress). Some sex-specific or demographic-specific recommendations do not perfectly apply to LGBTQ individuals due to insufficient research. Best practices
must therefore be extrapolated based on a combination of clinical consensus and what is known
about the pathophysiology of disease. Providers should therefore have and document “informed
consent” discussions with patients (see Part II) in order to choose the best treatment course.50
Many screening and preventive practices are best guided by reported patient behavior—particularly related to substance abuse, sexual practices, and mental health—rather than by identification
with a particular patient population. For example, a gay male patient with the same monogamous
male partner for 30 years who does not drink alcohol or use drugs, has no history of depression
or anxiety, is stably employed, and reports no current problems may not benefit from some of the
additional screenings often recommended for men who have sex with men, which are often based
on those with multiple sex partners. The sections below outline best behavior-based practices for
the LGBTQ/DSD communities and all patients.

preventive care
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Cancer Screenings – Decisions about cancer screening are complex and require consideration
of multiple factors. Patient anatomy and the underlying cancer risk for specific organs are factors
to consider. Common cancer screening guidelines for asymptomatic adults without a personal or
family history of cancer include:

20
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Few cancer databases collect data on sexual orientation or gender identity (but see The PRIDE
Study in Appendix A for research addressing this gap). However, evidence suggests that the
LGBTQ community suffers from higher rates of certain cancers compared to straight, cisgender
communities. These disparities may be caused by behavioral differences (such as anal cancer in gay
men67) or differences in accessing preventive care (such as cervical cancer in lesbian women, who
may visit the OBGYN less frequently because of not needing birth control68). Whether or not a
person with a DSD is at an increased risk for malignancy depends on the specifics of their DSD.
Providers must therefore research the needs for specific patients according to their past medical
history, hormonal profile, and present anatomy.
Gender-affirming care can affect screening recommendations because some risk factors may be
increased (trans women develop increased breast tissue while taking estrogen, requiring routine
screening) or decreased (trans men do not need cervical pap tests after having a total hysterectomy
removing the cervix). This underscores the importance of establishing a trusting relationship with
patients to gather a complete history that includes current anatomy to make appropriate cancer
screening recommendations. Patient anatomy and the underlying cancer risk for specific organs
should be considered. For example, when considering cervical cancer screening, the first question
should be “does this patient have a cervix?” but other factors such as time since last Pap test, prior
abnormal cytology, sexual history, and underlying immunosuppressed state are also considered.
When designing a cancer screening strategy for LGBTQ and DSD-affected patients, evaluation of
the traumatic versus affirming nature of some invasive exams or procedures must also be considered and discussed with the patient. The clinician should talk through the benefits, risks, and
alternatives with each patient, based on their individual anatomy as well as related risk behaviors.
A mammogram on a trans man (FSAAB) who uses chest binding and has not had a mastectomy
may be very disruptive but necessary if there is a strong family history of breast cancer; the same
mammogram may also be medically necessary and seen as an identity-affirming step in gender
transition by a trans woman (MSAAB) who has had breast augmentation surgery, and takes
hormones to supplement breast development. Note that providers may have to help patients file
claims with insurance companies if the patient has changed their gender identity on their identification but screenings do not align with gender identities expected by insurance companies (e.g., a
prostate screening for a (trans) woman or a cervical screening for a (trans) man—see Part IV).
Sexual Health Screening and Preventive Prescribing – Preventive health recommendations
related to sexual health like regular HIV and STI screening are dependent on taking a full sexual
history (see Part I). Nonjudgmentally determine specific types of sexual behavior that the patient
engages in (“what goes where?”) because vaginal, oral, anal, and other sexual practices carry
different health risks for all populations. Many older adults are also sexually active but are often
overlooked for sexual health screenings,69 which may contribute to STI transmission risks.70
Determine how patients protect themselves from HIV, STIs, and unwanted pregnancies, as well
as their (and ideally their partner’s) past history with any of these conditions. It is also important to screen all patients for high-risk sexual behaviors, including alcohol/drug use during sex or
exchanging sex for money, drugs, or housing. This information is crucial to know for all patients,
not just LGBTQ patients.
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Providers should become comfortable discussing sexual history in
a neutral, nonjudgmental way with all patients. A thorough sexual
history should be completed for every new patient in a primary
care setting. Remember to
1) indicate that all patients are asked this information,
2) describe how this information is used to provide them
appropriate care, and
3) explain to patients that this information is confidential.

PrEP and PEP – Pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) are
biomedical treatments that lower a person’s risk of contracting HIV. PrEP is a daily, oral medication prescribed to HIV-negative patients who disclose high-risk behaviors (e.g., unprotected sex
with one or more people who are HIV positive or whose HIV status is unknown, sex under the
influence of drugs/alcohol, injection drug use) and want to decrease their risk of contracting HIV.
PrEP is over 90% effective at preventing HIV transmission, but its effectiveness is greatly reduced
if it is not consistently taken.71 Patients taking PrEP still need to use condoms to prevent transmission of other STIs. PEP is antiretroviral drugs taken as an emergency intervention within 72
hours of exposure to a high-risk event to reduce the likelihood of HIV seroconversion.72
When physicians learn about high-risk behaviors, they often counsel the patient to stop the
behavior. However, behavioral choices about sex and substance use are extremely complex. Many
patients continue high-risk behaviors for a variety of reasons, including pleasure, affection, physical connection, substance addiction, and/or exchange for resources. One recommended strategy is
to nonjudgmentally assess how much the patient knows about HIV, then educate that individual
as needed about which behaviors carry a higher risk of contracting HIV and how to decrease the
risk of infection by taking medication (PrEP) daily. This gives a patient the option to express the
desire to try medication as a risk-reducing strategy recommended by their doctor. As with crosssex hormone therapy, physicians unfamiliar with prescribing HIV-related medications usually
overestimate the risk associated with taking PrEP/PEP. The Fenway Institute has a PrEP Action
Kit with information about prescribing and monitoring PrEP,73 and it is crucial for providers to
learn about the actual evidence for toxicity or adverse outcomes of PrEP/PEP and realistically
contrast this with each patient’s risk of contracting HIV related to their exposure behavior. As
with all preventive care and risk reduction strategies, providers should use behavioral rather than
demographic or sexual/gender identity information when recommending HIV screening, PrEP,
and PEP to patients. Cisgender straight patients who engage in the same high risk behavior (unprotected sex with one or more people who are HIV positive or whose HIV status is unknown,
sex under the influence of drugs/alcohol, injection drug use) also benefit from HIV screening,
PrEP, and PEP.
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VACCINES

Current vaccination considerations are typically based on cis-normative demographic information
that assumes behaviors. Multiple factors influence a patient’s personal health risk, including their
own practices as well as that of their current and previous partner(s). The use of barrier methods
during sexual activity may be low if partners cannot conceive or if an individual uses another
form of birth control,74-76 thus increasing the risk of some disease transmissions. Therefore, rather
than assessing risk based on demographic factors (such as whether a person identifies as LGBTQ),
providers should determine risk based on the individual patient’s history and practices. However,
any patient’s behavior could change at any time. The provider should have a conversation about
the implication of future behavior change if the provider (and/or the patient) were to determine
that vaccination is not indicated at this time. Regional recommendations may vary depending on
local outbreaks (e.g., current outbreaks of Hepatitis A for the general population in Kentucky77
and meningitis outbreaks among men who have sex with men in New York City78). The following
page shows behavior-based recommendations for some common vaccinations.
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REPRODUCTION AND FAMILY PLANNING

Some aspects of reproduction and family planning have special considerations for LGBTQ/DSD
individuals. It is important to avoid making assumptions about LGBTQ/DSD patients’ parenting desires. Instead, ask about their goals, then help them determine their parenting options.
These patients experience multiple obstacles to becoming parents, such as financial burdens (e.g.,
the cost of fertility treatments, surrogacy, or adoption), social challenges (e.g., discrimination of
reproductive endocrinology programs and adoption agencies), and legal hurdles (e.g., adoption
rights by LGBTQ people is being litigated in some states, and local laws regarding surrogacy and
donor gametes vary). However, all major professional health organizations have issued statements
supporting adoption and parenting by LGBTQ individuals.85 In addition, providers should be
aware of the many microaggressions experienced by LGBTQ patients related to family planning
(such as asking “Who’s the real mother?” or “Did you use a sperm donor?”—see Part I). For
LGBTQ families, providers can avoid using the names “mother” and “father” until they establish
what terminology the parents use at the first visit. Support, affirmation, and acceptance is crucial
in a world that often perceives LGBTQ/DSD people as different or objects of inappropriate and
invasive curiosity.
Contraception – Understanding sexual behavior of patients is important to determine what,
if any, contraception is needed (in addition to safe-sex practices). For DSD-affected patients,
providers must discuss contraception goals and suitability for the specific patient dependent on
past medical history, hormonal profile, and present anatomy. Sexual exploration with partners of
male, female, or another gender is extremely common (particularly among LGBTQ youth86,87),
and unplanned sexual encounters can and do occur. Emergency contraception is a critical part of
preventive care planning for patients who might conceive and do not wish to become pregnant,
and thus all patients should be made aware of emergency contraception as an option for current
or potential future sexual encounters.

Providers should affirm identities while counseling about contraception.
You can address contraception for patients who identify as gay or
lesbian and describe a history of only same-sex sexual encounters by
validating the patient’s current/past sexual behavior and indicating that
you tell all of your patients about this option because behavior changes
for some patients.

Although testosterone use typically prevents menses in patients on the female-to-male spectrum
who retain their natal reproductive organs, an ovulatory state with testosterone use is not uncommon—thus making it is possible for trans men to become pregnant. Progestin and estrogen-progestin hormonal birth control options may interfere with hormone therapy for transgender patients, and many trans men are hesitant to use hormonal birth control even if they are not taking
testosterone. Nonhormonal options, such as a copper intrauterine device (IUD), may be the best
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option to discuss (although a discussion regarding heavy bleeding associated with copper IUDs is
necessary). Barrier methods, including condoms or diaphragms, are other nonhormonal contraception options (keeping in mind that diaphragms do not provide STI protection and have higher
failure rates than other listed methods88). Similarly, estrogen use typically slows spermatogenesis in
male-to-female spectrum patients, but the patient may still produce sperm and theoretically could
impregnate a partner with a uterus. Thus, all transgender patients taking hormone therapy should
be counseled about contraception to determine the best options for them.
Fertility – DSD is associated with lower fertility, but in practice this will be highly patient-dependent.89 For transgender patients taking hormones, fertility may be reduced with hormone use, and
the reversibility of these effects are not definitively understood. It is advised that the provider explore family planning goals and effects on fertility before the patient transitions.8 This is challenging for providers caring for transgender youth and will likely require subspecialty and counseling
expertise.6 If a trans man desires to become pregnant, he should be advised to cease testosterone
use before attempting to become pregnant because of adverse effects on the fetus. Fertility preservation options for transgender patients desiring to start (and not later cease) hormone therapy
include cryopreservation (“banking”) of sperm, oocyte, embryo, and ovarian or testicular tissue.6,90
Family Planning Options – Like the broader population, LGBTQ/DSD people who want to
parent have multiple options for achieving this goal. Unlike many non-LGBTQ/DSD people,
they are impacted by “social infertility,” as they are unable to conceive because of social, rather
than solely medical factors.91 The following table details concepts of assisted reproduction and the
primary ways LGBTQ/DSD people become parents. The diversity of LGBTQ/DSD individuals
and families means that a clinician cannot make assumptions about how a given LGBTQ/DSD
identity becomes a family. Instead, providers should familiarize themselves with options available
and ask for details as appropriate. Providers should be aware that not all options are available
in all communities, and many are not covered by most health insurance policies and thus may
be cost-prohibitive. New options (e.g., mitochondrial donation/three parent IVF) may become
available in the future.
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Providers who care for children should be aware of the needs of
LGBTQ parents. Historically, LGBTQ parents had difficulty establishing
full rights for both parents. When such recognition was possible, it
usually involved prohibitively expensive legal procedures. While legal
recognition of LGBTQ families has improved, some LGBTQ people
do not have access to these processes. Lack of such recognition
is problematic in the health care setting, as LGBTQ parents may be
asked to “prove” their relationship to their children in order to seek
treatment for them. LGBTQ parents are parents regardless of whether
they have a genetic link to their children. Some health concerns and
questions are related to genetics, but many are not. Communicate
with LGBTQ parents on why genetic history may be relevant. Ask
questions about genetics and family formation with sensitivity, and
remain open and welcoming to the input of all parents, regardless of
their genetic link to the child.
Developing skills around inclusive communication regarding family
and reproduction (see Part 1) will benefit all of your patients, as
non-LGBTQ parents also form families through adoption, surrogacy,
gamete donation, and blending through remarriage.
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PART IV: SOCIAL DETERMINANTS OF HEALTH
SOCIAL DETERMINANTS OF HEALTH

Social determinants of health (SDOH) are structural factors that impact health, such as conditions in which an individual grows up or lives (see figure for some examples). These factors can
influence the psychological and physical well-being of patients. As a physician, it is important
to screen all patients and determine when it is appropriate to call in housing, social, or other
interprofessional support for patients. Providers should educate themselves about what services are
available in their city or region and consult these services if they feel that the patient is at immediate risk of hurting themselves or at risk of being hurt by their living conditions. The American
Academy of Family Physicians EveryONE project93 (see Appendix A) has excellent screening
resources for social needs.

Much of the information regarding SDOH is related to systemic factors and understanding
non-medical influences in LGBTQ/DSD patient health. Every preventive health visit needs to
revisit questions of social determinants of health for all patients. Providers should avoid the assumption that an individual’s living situation, employment, relationships, risk behaviors, or identities remain static from visit to visit. Below are additional considerations that affect the psychological and social aspects of patients’ health. Because of the high prevalence of some psycho-social
issues in the LGBTQ/DSD population, providers should make LGBTQ/DSD patients aware of
the availability of mental health, substance abuse, intimate partner violence, and social support
services if they or someone they know ever needs to access these services. Providers who work in
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a setting without an up-to-date, single-source list of community resources will need to rely on
internet searches and real time networking with other providers and community organizations
to find the right resource(s) for patients. If social work and/or case management services through
the provider’s clinic are available, the provider should attempt to set up a social work consultation
and connect to social services to address any SDOH concerns by using healthcare systems tools to
provide interdisciplinary support. The following table provides an overview of SDOH that impact
all patients, with particular relevance to LGBTQ and/or DSD-affected people. (See Appendix A
for follow-up resource links).
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LEGAL AND INSURANCE CONSIDERATIONS

When making recommendations to patients, insurance coverage or lack thereof is an important
consideration. LGBTQ individuals are less likely to be insured than cis/heterosexual counterparts.12,105 Services based on behavior may also fall outside of demographic-based guidelines (e.g.,
anal pap tests). Providers should familiarize themselves with coverage policies regarding these
recommendations so that they may 1) have an informed conversation with patients to allow them
to consider the benefit of screening versus potential out-of-pocket costs and 2) help patients apply
to the insurance provider for an exception to noncovered services with an appropriate rationale
outside the guidelines. If noncovered services are unaffordable for a patient, providers should
consider whether there are other measures that the patient could take to lower their risk. Providers should also reach out to clinic case management services to identify resources. The Centers
for Medicare and Medicaid Services (CMS) and The National Uniform Billing Committee have
approved a special billing code (condition code 45 - Ambiguous Gender Category) to alleviate
situations where claims are incorrectly denied for transgender and DSD-affected beneficiaries
because of a mismatch between the gender marker and the billing service.108
Structural barriers that affect LGBTQ and DSD health include legal and insurance policies that
allow discrimination against LGBTQ and DSD-affected individuals. Many of these policies vary
from state to state, but providers should be aware of policies such as unequal, patchwork, and
cost–prohibitive insurance coverage for domestic partnerships in private and public sectors; employer-based insurance that allows discrimination for sex and gender minorities; Title IX coverage
of gender identity; and state-by-state policies allowing discrimination based on sexual orientation
and/or gender identity for job, housing, and some public services. Other public policies have
shown growth, including LGBTQ health included as federal priority in Healthy People 2020.
Expanded Affordable Care Act (ACA) regulations and insurance access allowed many people
who had not previously received coverage to do so, including those with preexisting conditions;
protections against insurance discrimination for sex and gender minorities (ACA Section 1557)
also improved coverage for many LGBTQ individuals. However, many of these policies are in
flux, so providers will need to determine how changes to public policy affect their LGBTQ and
DSD-affected patients.
Name and gender-change processes for identification documents can be prohibitively complicated
and expensive for transgender patients. One third of transgender people have not updated any
IDs after transitioning,12 and many encounter insurance and legal issues (e.g., starting jobs, traveling) when 1) their used name does not match their legal name or appearance or 2) when ordered
preventive/diagnostic care does not match the sex on insurance identification (but see above).
For the patient, navigating these systems can be a significant source of stress. Trans social support
networks and advocacy groups are excellent resources for advice and supportive services. State-bystate ID policies can be found at the National Center for Transgender Equality (see Appendix A).

To change some identification documents, transgender patients must
obtain a letter from their provider confirming their gender transition.
Providers should indicate that the patient “has transitioned” under the
provider’s care rather than “is transitioning.” The language used in the
letter is consequential, and it is important to refer to the transition in past
tense. For example, adult patients with a past-tense letter will be issued
a standard 10-year passport, whereas with a present-tense letter only a
limited validity 2-year passport is issued.

30

eQuality Toolkit

PART V: SENSITIVE PHYSICAL EXAMS
KNOW YOUR PATIENT

Physical examinations, particularly of sensitive parts of the body, such as genitals or breasts/chest,
can be distressing to any patient. These exams can be more challenging for patients who have
experienced trauma (e.g., sexual abuse), mistreatment (e.g., voyeuristic or inappropriately curious/
intrusive behavior from previous providers), or gender dysphoria (e.g., the existence of body parts
that do not match an individual’s gender identity).
To prepare for sensitive exams, the provider should discuss why the exam is important and ask
about the patient’s experiences with previous exams.7 This enables the provider to address any
anxiety the patient feels about proceeding with the exam and discuss options to make their experience less stressful. It is important to note that not all LGBTQ patients and individuals born with
DSD have experienced trauma, but the guiding principles of trauma-informed care for physical
exams can help build a trusting relationship between providers and all patients.109 They include
1) placing control over consent to the exam and ability to stop the exam with the patient,
2) engaging in shared decision-making of examination options (positioning, chaperones,
etc.),
3) explaining the procedure by narrating each step and using preferred terminology,
4) informing the patient that modifications to the procedure are available, and
5) acknowledging and validating a history of trauma and/or previous negative experiences.

INCLUSIVE LANGUAGE FOR EXAMS AND ENCOUNTERS

Mirroring a patient’s own language in regard to anatomical terms can facilitate comfort during
sensitive exams, particularly for patients who providers have established are not cisgender. During
initial discussions, providers should ask patients how they refer to their body parts or specific
bodily functions since language used will be patient-specific (“What language do you typically
use when talking about your body?”). For patients who are on the male-to-female spectrum or
female-to-male spectrum, providers should also choose words that are less gendered to provide a
less stressful environment for a medical history and/or exam. Examples include:
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Other language choices can help optimize the comfort of patients during sensitive exams:

STRATEGIES AND OPTIONS TO OPTIMIZE COMFORT

Trauma-informed care (see Part III) involves empowerment, voice, and choice. In addition to
language choices, there are other ways for providers to optimize comfort for all patients during
sensitive exams, including offering alternative screening options compared to more invasive clinical screenings (see the following page). General strategies also include allowing other providers
(e.g., of a different gender) to perform the test, allowing the patient to bring a support person to
the appointment, and ensuring that the patient understands that they can ask to stop the exam.7
Many postoperative transgender patients and DSD-affected individuals report that providers have
allowed students or other providers to watch sensitive examinations or perform an additional
examination.38,39 This is a significant problem because it dehumanizes and objectifies patients.
Providers have a responsibility to prevent this voyeuristic behavior, even in the context of teaching. If it is appropriate for a learner to be present, the provider should ask for the permission of
the patient and limit the number of learners in the room. Before any exam, the provider should
also discuss how the patient can stop the exam if necessary. If an exam is stopped due to patient
distress, the provider should ensure that the patient has ample opportunity to reconstitute and has
a firm self-care plan before leaving the office.110

Trauma-informed care involves empowerment, voice, and choice.
This benefits all patients, regardless of their past experiences and
medical history. The principles of trauma-informed care can improve
all patients’ experiences in all exams and medical encounters.

Gynecologic and Genitourinary Exams – Pelvic exams and cervical screenings are part of routine care, but they can feel invasive to many patients. Bimanual exams are indicated in symptomatic patients (e.g., pelvic pain) but not for screening asymptomatic patients.57 For patients who
feel uncomfortable with gynecologic exams, various steps make the experience more comfortable
for the patient.110 The clinic should identify patient preferences toward the gender of the provider and/or chaperone, if desired; it’s important to make sure that required chaperones are not
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perceived as voyeurs. The provider can make accommodations such as allowing the patient to only
partially undress or not requiring use of foot rests or a lithotomy position. If discomfort or pain is
a concern, the provider can use a small or pediatric speculum or an anoscope rather than a vaginal
speculum. Low-dose topical estrogen can be administered to patients for one to two weeks before
the exam to reduce cervical atrophy, although patients on the female-to-male spectrum may not
want to introduce estrogen into their bodies. For male-to-female spectrum patients, a gynecologic
exam can be affirming for those who have a neovagina. Other patients may “tuck” their testicles
into the inguinal canal and penis/scrotum posteriorly in the perineal region, which can cause
complications like urinary trauma or hernias.6 Sensitively asking patients about the role of tucking
in their well-being and any concerns allows the provider to educate about safety (e.g., not tucking
as tightly).111
Anal/Rectal Exams – Comfort can be increased by ensuring that the patient maintains the locus
of control during the exam and giving the patient options. Positioning for anal or rectal exams
can be done standing, leaning, lying on the side, supine, and supine with the feet together and
knees apart to expose the perineum. In practice, clinicians examining cis men usually perform
digital rectal exams standing, although studies suggest that these patients actually prefer having
the exam lying on their side.112 Providers should use adequate lubricant, describe all steps of the
procedure to the patient, and ask permission prior to proceeding.
Breast/Chest exams – Clinical breast exams are no longer recommended for routine cancer
screening in asymptomatic patients,54 but patients may present with conditions that indicate
breast or chest examination. Providers should apply the same principles of trauma-informed care
described above to breast and chest exams: explain the purpose and steps of the exam, obtain
permission, proceed matter of factly, let the patient stop at any time, and use inclusive language.
To create a flat chest appearance, some patients on the female-to-male spectrum may bind their
chests with tight fitting sports bras, bandages, or binders created specifically for this purpose.
These products may irritate the chest skin, cause fungal infections, and lead to other health
issues.113 Providers are advised to discuss binding practices and work with the patient to mitigate
risk (e.g., by recommending “off days” if possible or hygienic practices to avoid infections).6,113
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Alternatives to Clinical Exams – In some cases, patients may be able to complete routine testing
through at-home sample collections rather than at a healthcare facility. These options could be
desirable for patients who may feel uncomfortable in certain healthcare settings (e.g., frontal
self-swabs for HPV for trans men who may feel uncomfortable visiting a gynecologist’s office and
would otherwise forego cervical cancer screening).
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CONCLUSION
NEXT STEPS

At the end of the content section of this manual, you should now be ready to employ the best
practices that you have learned in this manual. As a reminder, this intervention is meant to provide a nuts and bolts approach to LGBTQ health—you will learn much more by having thoughtful, open conversations with all of your patients.

LGBTQ health is a rapidly evolving area, so providers must be sure to
use lifelong learning skills to keep updated as new research findings
and best practices emerge. The goal is to always aspire to provide the
best possible care for each patient, regardless of sexual orientation or
gender identity.

Appendix A includes several nationally-renowned and evidenced-based resources to close any remaining knowledge gaps or to allow for more in-depth exploration of specific topics. One of the
best “go-to” resources is The National LGBT Health Education Center (part of the Fenway Institutute), which is an established resource for LGBTQ healthcare and has excellent online resources
for providers and patients. For specifics on transgender clinical care, The World Professional
Association for Transgender Health (WPATH) and The Center of Excellence for Transgender
Health out of the University of California, San Francisco provide detailed, evidence-based clinical
recommendations and research summaries. You will find links to these and other comprehensive
resources on the following page.
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APPENDIX A - NATIONAL RESOURCES
LGBTQ/DSD HEALTHCARE RESOURCES FOR PROVIDERS AND PATIENTS

These comprehensive, definitive healthcare resources can supplement your primer on LGBTQ/
DSD health, and many provide excellent information for patients as well.
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LGBTQ/DSD COMMUNITY AND SUPPORT RESOURCES

Below are resources for LGBTQ/DSD patients, including national and regional organizations.
Visit the eQuality website (louisville.edu/medicine/equality/) for a full list of local and regional
resources for Louisville, Kentucky. For providers and medical educators outside of Louisville, local
resources can be found by contacting affiliated campus LGBTQ student services or by contacting
a local LGBTQ services center, which can be identified through the CenterLink LGBT Community Center Member Directory (https://www.lgbtcenters.org/LGBTCenters).
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APPENDIX B – GLOSSARY

Definitions are sourced and adapted from The Safe Zone Project.120

Ally – (noun) a (typically straight‐ or cis‐identified) person who supports and respects members of
the LGBTQ community. While the word does not necessitate action, we consider active allies to be
people who take action upon this support and respect, which also demonstrates to others that you
are an ally.
Asexual – (adjective) having a lack of (or low level of) sexual attraction to others and/or a lack of
interest or desire for sex or sexual partners.
Biological Sex – (noun) a medical term used to refer to the chromosomal, hormonal and anatomical
characteristics that are used to classify an individual as female or male or intersex. Often referred to
as simply “sex,” “physical sex,” “anatomical sex,” or specifically as “sex assigned [or designated] at
birth (SAAB).”
Bisexual – (adjective) a person emotionally, physically, and/or sexually attracted to male/men and
females/women. Other individuals may use this to indicate an attraction to individuals who identify
outside of the gender binary as well and may use bisexual as a way to indicate an interest in more
than one gender or sex (i.e. men and genderqueer people). This attraction does not have to be equally
split or indicate a level of interest that is the same across the genders or sexes an individual may be
attracted to.
Cisgender – (adjective, pronounced “siss‐jendur”) a person whose gender identity and biological sex
assigned at birth align (e.g., man and male‐assigned). A simple way to think about it is if a person is
not trans, they are cisgender. The term “cisgendered” is a common mistake.
Cisnormativity – (noun) the assumption, in individuals or in institutions, that everyone is cisgender,
and that cisgender identities are superior to trans identities or people. Leads to invisibility of noncisgender identities.
Coming Out – (verb) (1) the process by which one accepts and/or comes to identify one’s own sexuality or gender identity (to “come out” to oneself). (2) The process by which one shares their sexuality
or gender identity with others (to “come out” to friends, etc.).
Differences of Sexual Development (DSD) - (noun) someone whose combination of chromosomes,
gonads, hormones, internal sex organs, and genitals differs from the two expected patterns of male or
female; sometimes referred to as intersex; formerly known as hermaphrodite (or hermaphroditic), but
these terms are now considered outdated and derogatory. Some texts still use “Disorders” of Sexual
Development for DSD, which patients also find demeaning.
Feminine Presenting; Masculine Presenting ‐ (adjective) a way to describe someone who expresses gender in a visibly feminine or masculine way (for example in hair style, demeanor, clothing
choice, or style) that is characteristic or associated with the gender concepts in a given society.
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FSAAB – (adjective) abbreviation for female sex assigned at birth.
FtM/F2M; MtF/M2F – (adjective) abbreviation for female‐to‐male transgender person; abbreviation
for male‐to‐female transgender person.
Gay – (adjective) (1) a term used to describe individuals who are primarily emotionally, physically,
and/or sexually attracted to members of the same sex and/or gender. More commonly used when
referring to males/men‐identified people who are attracted to males/men‐identified people, but can
be applied to females/women‐identified people as well. (2) An umbrella term used to refer to the
queer community as a whole, or as an individual identity label for anyone who does not identify as
heterosexual.
Gender Affirming Surgery – (noun) surgical options that alter a person’s biological anatomy. “Sex
Reassignment Surgery” was a term used by some medical professionals, but gender affirming
surgery is considered to be a more appropriate term. Some people refer to the different surgical
procedures as “top” surgery (construction of a male‐type chest or breast augmentation for a female‐
type chest) and “bottom” surgery (various genital reconstruction surgeries that can involve genital
removal and/or genital construction) to discuss what type of surgery they are having without having
to be more explicit.
Gender Binary – (noun) the idea that there are only two genders – male/female (or man/woman)
and that a person must be strictly gendered as either/or.
Gender Expression – (noun) “gender presentation” or the external display of one’s gender through
a combination of dress, demeanor, social behavior, and other factors; generally measured on scales
of masculinity and femininity. Note that gender expression may not always match a person’s actual
gender identity (i.e., you can’t always know someone’s gender identity by looking). Some people may
also express a gender because of safety or work/family/social expectations, but may actually have a
different gender identity than that presented.
Gender Fluid ‐ (adjective) gender fluid is a gender identity best described as a dynamic mix of male
and female. A person who is gender fluid may always feel like a mix of the two traditional genders,
but may feel more man some days, and more woman other days.
Gender Identity – (noun) the internal perception of one’s gender, and how they label themselves,
based on how much they align, or do not align, with what they understand their options for gender to
be. Common identity labels include man, woman, genderqueer, trans, and more.
Gender Non‐Conforming (GNC) ‐ (adjective) someone whose gender presentation, whether by
nature or by choice, does not align in a predictable fashion with gender‐based expectations.
Genderqueer ‐ (adjective) a gender identity label often used by people who do not identify with the
binary of man/woman; or as an umbrella term for many gender nonconforming or nonbinary identities (e.g., agender, bigender, genderfluid).
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Heteronormativity – (noun) the assumption, individually or institutionally, that everyone is heterosexual, and that heterosexuality is the norm or is superior to all other sexualities; can lead to the
invisibility or stigmatizing of other sexualities. Often included in this concept is a level of gender
normativity and gender roles, the assumption that individuals should identify as men and women,
and be masculine men and feminine women, or that men and women are the expected complementary pair.
Heterosexual – (adjective) a person primarily emotionally, physically, and/or sexually attracted to
members of the opposite sex. Also known as straight.
Homophobia/Biphobia/Transphobia – (nouns) umbrella terms for a range of negative attitudes
(e.g., fear, anger, intolerance, resentment, erasure, or discomfort) and policies that an individual or institution may have against members of LGBTQ community. The term can also connote a fear, disgust,
or dislike of being perceived as LGBTQ.
Homosexual – (adjective) a [medical] term used to describe a person primarily emotionally, physically, and/or sexually attracted to members of the same sex/gender. This term is considered stigmatizing
due to its history as a category of mental illness, and is discouraged for common use (use gay or
lesbian instead).
Lesbian – (noun) a term used to describe women attracted romantically, erotically, and/or emotionally to other women.
MSAAB – (adjective) abbreviation for male sex assigned at birth.
MSM/WSW ‐ (noun) initialisms for “men who have sex with men” and “women who have sex with
women,” to distinguish sexual behaviors from sexual identities (e.g., because a man is straight, it
doesn’t mean he’s not having sex with men).
Nonbinary - (adjective) umbrella term for genders that are not exclusively male/female (such as
agender, bigender, genderfluid, genderqueer), and for individuals who may identify as nonbinary.
Outing – (verb) involuntary or unwanted disclosure of another person’s sexual orientation, gender
identity, or intersex status.
Questioning – (verb, adjective) exploring one’s own sexual orientation or gender identity or an
individual who is exploring their own sexual orientation and gender identity.
Queer – (adjective) used as an umbrella term to describe individuals who don’t identify as straight;
also used to describe people who have nonnormative gender identities. Queer is not used or embraced by all LGBTQ community members due to its historical derogatory use, but through linguistic
reclamation it is indeed self-used by many LGBTQ community members.
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Sex Assigned at Birth (SAAB) – (noun) a phrase used to distinguish between the sex that was
assigned to an individual (typically male or female) and gender identity, which may not be the same.
Same Gender Loving/SGL – (adjective) a term traditionally used by members of the African‐American/Black community to express an alternative sexual orientation without the perceived social or
political implication of the term gay or lesbian.
Sexual Orientation – (noun) the type of sexual, romantic, emotional/spiritual attraction one feels for
others, often labeled based on the gender relationship between the person and the people they are
attracted to (often mistakenly referred to as sexual “preference”).
Third Gender – (noun) a person who does not identify with either man or woman, but identifies with
another gender. This gender category is used by societies, both contemporary and historic, that recognize three or more genders; is also a conceptual term meaning different things to different people
who use it as a way to move beyond the gender binary.
Trans/Transgender – (adjective) (1) an umbrella term covering a range of identities that transgress
socially defined gender norms or (2) a person who lives as a member of a gender other than that
expected based on sex assigned at birth.
Transition(ing) – (noun, verb) primarily used to refer to the process a trans person undergoes when
changing their bodily appearance either to be more congruent with the gender/sex they feel themselves to be and/or to be in harmony with their preferred gender expression.
Two‐Spirit – (noun) is an umbrella term traditionally used by Native American people to recognize
individuals who possess qualities or fulfill roles of both genders.
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